Respiratory drugs

These companies make drugs for lung conditions such as asthma, COPD, bronchiectasis and chronic cough.
−5.3%
over 3 months · S&P 500 −2.1%

Key indicators

Health
51 / 100
Fragile
Solid
Price
P/E 16
Cheap
Expensive
Up over 1 year
6 of 11
Volatility
59%
Calm
Choppy
Health and price: against the other tags.